Krebs Biochemicals & Industries (BOM:524518) Other Current Receivables: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524518 Krebs Biochemicals & Industries Ltd BOM:524518
41 GF Score
Price ₹56.43
GF Value ₹43.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krebs Biochemicals & Industries Other Current Receivables?

Krebs Biochemicals & Industries BOM:524518 -2.34% 41 Other Current Receivables is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:524518 with a GF Score™ of 41/100 and a GF Value™ of ₹43.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Krebs Biochemicals & Industries's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Krebs Biochemicals & Industries's annual Other Current Receivables declined from Mar. 2024 (₹29.91 Mil) to Mar. 2025 (₹1.74 Mil) and declined from Mar. 2025 (₹1.74 Mil) to Mar. 2026 (₹0.00 Mil).

Krebs Biochemicals & Industries Other Current Receivables Related Terms

Krebs Biochemicals & Industries Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Krebs Biochemicals & Industries's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries Other Current Receivables Chart

Krebs Biochemicals & Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.97 2.62 29.91 1.74 0.00

Krebs Biochemicals & Industries Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:524518
41GF Score
Krebs Biochemicals & Industries Ltd BOM:524518
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krebs Biochemicals & Industries Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0.0 Mil mean?
Krebs Biochemicals & Industries (BOM:524518) has a Other Current Receivables of ₹0.0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Krebs Biochemicals & Industries and its competitors.
Is Krebs Biochemicals & Industries' Other Current Receivables too high?
Krebs Biochemicals & Industries' current Other Current Receivables is ₹0.0 Mil. Overall, Krebs Biochemicals & Industries has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krebs Biochemicals & Industries' Other Current Receivables compare to ZTS?
Krebs Biochemicals & Industries' Other Current Receivables of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Krebs Biochemicals & Industries and its competitors. Krebs Biochemicals & Industries's current Other Current Receivables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krebs Biochemicals & Industries stock overvalued right now?
Based on GuruFocus' analysis, Krebs Biochemicals & Industries (BOM:524518) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹43.03, compared to a current price of ₹56.43 — trading 31.1% above its estimated fair value. The current Other Current Receivables is ₹0.0 Mil. Krebs Biochemicals & Industries' overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Krebs Biochemicals & Industries (BOM:524518), the current Other Current Receivables is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krebs Biochemicals & Industries (BOM:524518) Overvalued in 2026?

Based on GuruFocus' analysis, Krebs Biochemicals & Industries stock appears to be overvalued. The current stock price of ₹56.43 is trading 31.1% above its estimated GF Value™ of ₹43.03. GuruFocus considers Krebs Biochemicals & Industries to be Significantly Overvalued.

Key valuation signals for BOM:524518:

  • Other Current Receivables: ₹0.0 Mil
  • GF Value™: ₹43.03 vs. price of ₹56.43 (31.1% above fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the BOM:524518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krebs Biochemicals & Industries Business Description

Other Exchanges KREBSBIO:India
Address Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, AP, IND, 531 031
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
41GF Score

Get the complete analysis for BOM:524518

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹56.43
Price
₹43.03
GF Value